This practical guide reviews the principles of Assertive Community Treatment (ACT), presents key considerations for adapting ACT across various treatment settings, populations, and related domain areas, and provides practical guidance for navigating cross-cutting issues.

Drug Abuse Warning Network (DAWN): Drug-Related ED Visits Involving Suicide Attempts Short Report presents national estimates and characteristics of drug-related ED visits involving suicide attempts and the top substance involved in suicide attempts.

This guide examines the types of interventions that support successful reentry for adults with mental health conditions and/or substance use disorders who are leaving jail/prison.

This guide provides staff with knowledge and strategies to best support diverse rural communities. It considers risk factors, strengths, and common disaster reactions unique to rural communities to support best practices for ensuring disaster resilience and recovery.

This report will include data on the cost of CSC programs; how it is financed; case studies of cost reimbursement methodologies; funding options; trends in costs and financing for CSCs; data evaluation of Medicaid and private insurance coverage and barriers.

This document accompanies the Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. It offers information about child welfare systems and what the health care provider's role is in developing a Plan of Safe Care.

The second supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and professionals who provide services for them.

The third supplemental to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. A compendium of resources for professionals who work with parents involved with child welfare.

This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.